TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALT

Altimmune Inc

Healthcare · Biotechnology

3.30$ +0.6% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Altimmune Inc (ALT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 527 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
167 211 188 173 148 139 157 190 218 280 336 527
153 210 188 171 146 137 155 188 217 278 335 335
87 135 79 57 31 37 49 183 61 44 98 63
141 198 182 165 139 132 150 183 211 273 332 326
4.5 4.9 2.6 3.0 3.3 3.1 2.5 0.9 0.1 1.7 0.3 3.3
0.0 0.0 0.0
1.2
12
16 17 15 21 14 16 15 29 33 55 52 53
12 12 11 15 8.6 10 9.8 9.2 13 15 11 13
0.5 0.5 0.5 0.3 0.3 0.3 0.2 0.2 0.2 0.3 0.3
3.0 2.1 3.8 2.7 1.1 0.2 1.1 0.9 4.8 2.7 1.5 1.3
14 14 34 35 35
150 194 173 153 133 124 142 161 186 225 284 474
-435 -466 -491 -515 -538 -561 -581 -603 -622 -649 -672 -695
54 58 71 71 71 71 76 81 89 101 124 185

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?